PTC Therapeutics Strategy Shifts Toward Rare Disease Expansion After Strong Financial Results
PTC Therapeutics has entered a pivotal new chapter in its corporate history following a year characterized by significant portfolio rationalization and a
by 
Josh Weiner
Josh Weiner